|
POM121 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78634884662188E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.0961010704923E-13 |
| Normal-vs-Stage2 |
4.235500E-04 |
| Normal-vs-Stage3 |
1.34860000000625E-06 |
| Normal-vs-Stage4 |
1.775090E-04 |
| Stage1-vs-Stage2 |
4.317200E-01 |
| Stage1-vs-Stage3 |
3.072000E-01 |
| Stage1-vs-Stage4 |
1.985630E-01 |
| Stage2-vs-Stage3 |
9.937400E-01 |
| Stage2-vs-Stage4 |
7.926800E-01 |
| Stage3-vs-Stage4 |
7.469200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.03512770472025E-12 |
| Normal-vs-AfricanAmerican |
4.23210000000118E-05 |
| Normal-vs-Asian |
7.995700E-03 |
| Caucasian-vs-AfricanAmerican |
8.680200E-01 |
| Caucasian-vs-Asian |
4.047900E-02 |
| AfricanAmerican-vs-Asian |
2.366300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.34450048053736E-10 |
| Normal-vs-Female |
3.51940698806175E-14 |
| Male-vs-Female |
2.892200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.744470E-02 |
| Normal-vs-Age(41-60Yrs) |
3.76729758500005E-11 |
| Normal-vs-Age(61-80Yrs) |
2.73070455136804E-11 |
| Normal-vs-Age(81-100Yrs) |
1.259170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.065600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.927400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.325600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.089800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.815960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.787240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.150900E-04 |
| Normal-vs-Grade 2 |
1.15170095682515E-11 |
| Normal-vs-Grade 3 |
3.6309000250867E-09 |
| Normal-vs-Grade 4 |
2.815100E-04 |
| Grade 1-vs-Grade 2 |
1.687610E-02 |
| Grade 1-vs-Grade 3 |
1.369540E-02 |
| Grade 1-vs-Grade 4 |
1.048130E-02 |
| Grade 2-vs-Grade 3 |
5.222200E-01 |
| Grade 2-vs-Grade 4 |
3.032600E-01 |
| Grade 3-vs-Grade 4 |
5.979800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.77435843795593E-12 |
| Normal-vs-ccB subtype |
7.1642000110117E-09 |
| ccA subtype-vs-ccB subtype |
3.003600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.70206121103456E-12 |
| Normal-vs-N1 |
2.862000E-02 |
| N0-vs-N1 |
5.645400E-01 |
|
|
